本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Teladoc Health Inc.

8.14
-0.4900-5.68%
盘后8.140.00000.00%17:12 EST
成交量:1,048.67万
成交额:8,463.24万
市值:14.45亿
市盈率:-6.37
高:8.51
开:8.51
低:7.79
收:8.63
52周最高:15.21
52周最低:6.35
股本:1.77亿
流通股本:1.75亿
量比:0.87
换手率:6.00%
股息:- -
股息率:- -
每股收益(TTM):-1.2780
每股收益(LYR):-5.8702
净资产收益率:-15.42%
总资产收益率:-3.48%
市净率:1.04
市盈率(LYR):-1.39

数据加载中...

2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities